Related Experiment Video
Updated: May 5, 2026

08:02
Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood
Published on: January 6, 2022
1.8K
Development of Multi-Bioactive Driven Composite Plant Extracts and Functional Study in Mice and Piglets
Xin Tao1, Yongming Li1, Shujie Liu1
1Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Antioxidants (Basel, Switzerland)
|May 4, 2026
Summary
A novel multi-bioactive plant extract shows promise as a natural alternative to feed antibiotics in animal production. This extract improved growth performance and gut health in mice and piglets without adverse effects.
Area of Science:
- Animal Science
- Pharmacology
- Natural Product Chemistry
Background:
- Dietary antibiotics are widely used in animal production but raise concerns regarding antibiotic resistance.
- There is a growing need for safe and effective alternatives to promote animal growth and health.
Purpose of the Study:
- To develop a multi-bioactive composite plant extract as a potential substitute for feed antibiotics.
- To evaluate the efficacy and safety of the developed plant extract in animal models.
Main Methods:
- Selected five plant materials based on in vitro antibacterial, antioxidant, and anti-inflammatory screening.
- Formulated three composite extracts (C1, C2, C3) using orthogonal design.
- Conducted feeding trials in mice and piglets, assessing growth performance, hematological parameters, organ indexes, gut microbiota, and intestinal morphology.
Main Results:
- Plant extracts C1 and C2 showed no adverse effects on hematological parameters or organ indexes in mice.
- Supplementation with C1 or C2 significantly improved growth performance and modulated gut microbiota in mice.
- C1 and C2 restored intestinal morphology and immune responses in LPS-challenged mice, and C2 improved growth in piglets comparable to antibiotic use.
Conclusions:
- A multi-bioactive composite plant extract was successfully developed.
- The developed plant extract demonstrates potential as a safe and effective alternative to conventional feed antibiotics in animal production.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204

